Overview of Dr. Magge
Dr. Rajiv Magge is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from University of Pittsburgh School of Medicine and has been in practice 8 years. He is one of 484 doctors at New York-Presbyterian Hospital and one of 484 doctors at New York-Presbyterian Hospital who specialize in Neurology. He has more than 40 publications and over 500 citings.
Office
1305 York Avenue, 10th Floor
New York, NY 10021Fax+1 401-444-3056
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2010 - 2013
Brown UniversityInternship, Preliminary Year, 2009 - 2010
University of Pittsburgh School of MedicineClass of 2009
Certifications & Licensure
NY State Medical License 2013 - 2026
MA State Medical License 2010 - 2013
RI State Medical License 2009 - 2010- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas Start of enrollment: 2019 May 21
Publications & Presentations
PubMed
- [18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases.Jana Ivanidze, Arman Sharbatdaran, Aliah McCalla, Andrew Brandmaier, Eleni Andreopoulou
European Journal of Radiology. 2024-12-01 - 2 citations[Ga68] DOTATATE PET/MRI-guided radiosurgical treatment planning and response assessment in meningiomas.Jana Ivanidze, Se Jung Chang, Arsalan Haghdel, Joon Tae Kim, Arindam Roy Choudhury
Neuro-Oncology. 2024-08-05 - DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas.Joon Tae Kim, Se Jung Chris Chang, Arsalan Haghdel, Rohan R Ramakrishna, Susan C Pannullo
AJNR. American Journal of Neuroradiology. 2024-06-07
Journal Articles
- Molecular Pathogenesis and Emerging Treatment for GlioblastomaRajiv S Magge, Rohan Ramakrishna, World Neurosurgery
- Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic ResistanceEvan K Noch, Rohan Ramakrishna, Rajiv Magge, World Neurosurgery
- Advances in Glioblastoma Operative TechniquesRajiv Magge, Rohan Ramakrishna, World Neurosurgery
Press Mentions
Molecular Biomarker Found for Aggressive Form of Rare MeningiomaDecember 22nd, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
